A detailed history of Cryder Capital Partners LLP transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Cryder Capital Partners LLP holds 290,353 shares of TMO stock, worth $149 Million. This represents 10.35% of its overall portfolio holdings.

Number of Shares
290,353
Previous 290,353 -0.0%
Holding current value
$149 Million
Previous $161 Million 11.85%
% of portfolio
10.35%
Previous 10.06%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$541.52 - $599.02 $71.6 Million - $79.3 Million
-132,309 Reduced 31.3%
290,353 $161 Million
Q1 2024

May 02, 2024

BUY
$528.82 - $599.43 $9.67 Million - $11 Million
18,289 Added 4.52%
422,662 $246 Million
Q4 2023

Feb 09, 2024

BUY
$431.41 - $532.94 $5.3 Million - $6.55 Million
12,283 Added 3.13%
404,373 $215 Million
Q3 2023

Nov 07, 2023

SELL
$498.29 - $574.41 $651,763 - $751,328
-1,308 Reduced 0.33%
392,090 $198 Million
Q2 2023

Aug 03, 2023

SELL
$508.46 - $591.13 $652,354 - $758,419
-1,283 Reduced 0.33%
393,398 $205 Million
Q4 2022

Feb 02, 2023

SELL
$484.71 - $571.37 $18.3 Million - $21.6 Million
-37,847 Reduced 8.75%
394,681 $217 Million
Q3 2022

Nov 07, 2022

SELL
$507.19 - $604.49 $201,354 - $239,982
-397 Reduced 0.09%
432,528 $219 Million
Q2 2022

Aug 08, 2022

BUY
$500.9 - $612.21 $15.3 Million - $18.7 Million
30,608 Added 7.61%
432,925 $235 Million
Q1 2022

May 09, 2022

BUY
$524.0 - $644.92 $8.11 Million - $9.98 Million
15,481 Added 4.0%
402,317 $238 Million
Q3 2021

Nov 04, 2021

BUY
$509.53 - $609.78 $1.81 Million - $2.17 Million
3,555 Added 0.93%
386,836 $221 Million
Q2 2021

Aug 09, 2021

BUY
$441.0 - $508.24 $37.4 Million - $43 Million
84,694 Added 28.36%
383,281 $193 Million
Q1 2021

May 14, 2021

BUY
$439.85 - $518.83 $2.81 Million - $3.32 Million
6,398 Added 2.19%
298,587 $136 Million
Q4 2020

Feb 08, 2021

SELL
$435.06 - $527.66 $27 Million - $32.8 Million
-62,130 Reduced 17.54%
292,189 $136 Million
Q1 2020

May 05, 2020

SELL
$255.3 - $340.05 $11.2 Million - $14.9 Million
-43,861 Reduced 11.02%
354,319 $100 Million
Q4 2019

Feb 04, 2020

SELL
$271.93 - $328.04 $4.33 Million - $5.22 Million
-15,908 Reduced 3.84%
398,180 $129 Million
Q3 2019

Oct 31, 2019

BUY
$268.46 - $305.43 $3.61 Million - $4.1 Million
13,438 Added 3.35%
414,088 $121 Million
Q1 2019

May 03, 2019

BUY
$212.17 - $273.72 $656,878 - $847,437
3,096 Added 0.78%
400,650 $110 Million
Q4 2018

Feb 06, 2019

SELL
$208.47 - $251.98 $2.44 Million - $2.94 Million
-11,681 Reduced 2.85%
397,554 $89 Million
Q3 2018

Nov 07, 2018

BUY
$205.57 - $244.32 $121,697 - $144,637
592 Added 0.14%
409,235 $99.9 Million
Q2 2018

Aug 13, 2018

BUY
$203.14 - $219.53 $32.7 Million - $35.4 Million
161,130 Added 65.1%
408,643 $84.6 Million
Q1 2018

Apr 25, 2018

BUY
$192.98 - $224.11 $2.32 Million - $2.69 Million
12,000 Added 5.1%
247,513 $51.1 Million
Q4 2017

Jan 29, 2018

BUY
$182.03 - $200.37 $7.67 Million - $8.45 Million
42,153 Added 21.8%
235,513 $44.7 Million
Q3 2017

Oct 23, 2017

BUY
$171.74 - $194.04 $33.2 Million - $37.5 Million
193,360
193,360 $36.6 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Cryder Capital Partners LLP Portfolio

Follow Cryder Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cryder Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Cryder Capital Partners LLP with notifications on news.